GSK
838 hedge funds and large institutions have $12.4B invested in GSK in 2020 Q2 according to their latest regulatory filings, with 90 funds opening new positions, 270 increasing their positions, 320 reducing their positions, and 62 closing their positions.
Holders
838
Holders Change
+22
Holders Change %
+2.7%
% of All Funds
17.23%
Holding in Top 10
12
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-25%
% of All Funds
0.25%
New
90
Increased
270
Reduced
320
Closed
62
Calls
$94.9M
Puts
$71.7M
Net Calls
+$23.2M
Net Calls Change
-$25.2M
Top Buyers
Top Sellers
1 |
1
Boston Partners
Boston,
Massachusetts
|
$248M |
2 |
2
Nuveen Asset Management
Chicago,
Illinois
|
$11.9M |
3 |
3
Renaissance Technologies
New York
|
$838M |
4 |
4
Dodge & Cox
San Francisco,
California
|
$1.69B |
5 |
5
Morgan Stanley
New York
|
$135M |